blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP4299123

EP4299123 - COMPOUNDS AND COMPOSITIONS FOR INDUCING CHONDROGENESIS [Right-click to bookmark this link]
StatusThe application has been published
Status updated on  01.12.2023
Database last updated on 05.10.2024
Most recent event   Tooltip13.09.2024Amendment by applicant 
Applicant(s)For all designated states
Novartis AG
Lichtstrasse 35
4056 Basel / CH
[2024/01]
Inventor(s)01 / CHOI, Ha-Soon
San Diego, 92121 / US
02 / JIANG, Jiqing
San Diego, 92121 / US
03 / LAJINESS, James Paul
San Diego, 92121 / US
04 / NGUYEN, Bao
San Diego, 92121 / US
05 / PETRASSI, Hank Michael James
San Diego, 92121 / US
06 / WANG, Zhicheng
San Diego, 92121 / US
 [2024/01]
Representative(s)Mueller, Philippe
Novartis Pharma AG
Patent Department
Lichtstrasse 35
4056 Basel / CH
[2024/01]
Application number, filing date23203447.007.06.2018
[2024/01]
Priority number, dateUS201762517394P09.06.2017         Original published format: US 201762517394 P
[2024/01]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report 
No.:EP4299123
Date:03.01.2024
Language:EN
[2024/01]
Type: A3 Search report 
No.:EP4299123
Date:03.04.2024
Language:EN
[2024/14]
Search report(s)(Supplementary) European search report - dispatched on:EP29.02.2024
ClassificationIPC:C07D493/08, A61K45/06, A61P19/02
[2024/14]
CPC:
C07D493/08 (EP,EA,IL,KR,US); A61P19/02 (EP,EA,IL,KR); A61K31/343 (IL,US);
A61K31/4427 (KR); A61K31/444 (KR); A61K45/06 (EP,IL);
A61K9/0053 (IL,US); C12N5/0655 (KR); C12N2501/999 (KR);
C12N2506/14 (KR) (-)
Former IPC [2024/01]A61P19/02
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2024/01]
Extension statesBANot yet paid
MENot yet paid
Validation statesMANot yet paid
TitleGerman:VERBINDUNGEN UND ZUSAMMENSETZUNGEN ZUR INDUKTION VON CHONDROGENESE[2024/01]
English:COMPOUNDS AND COMPOSITIONS FOR INDUCING CHONDROGENESIS[2024/01]
French:COMPOSÉS ET COMPOSITIONS D'INDUCTION DE LA CHONDROGENÈSE[2024/01]
Examination procedure09.09.2024Amendment by applicant (claims and/or description)
Parent application(s)   TooltipEP18737718.9  / EP3634967
EP21178695.9  / EP3915994
Fees paidRenewal fee
13.02.2024Renewal fee patent year 03
13.02.2024Renewal fee patent year 04
13.02.2024Renewal fee patent year 05
13.02.2024Renewal fee patent year 06
30.05.2024Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[IDA]WO2015175487  (NOVARTIS AG [CH], et al)
by applicantWO2011008773
 WO2012129562
 WO2015175487
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.